The LungVision navigational platform for peripheral lung nodule biopsy and the added value of cryobiopsy
Autor: | Moshe Heching, Shimon Izhakian, Barak Pertzov, Evgeni Gershman, Dror Rosengarten, Shai Moshe Amor, Mordechai R. Kramer |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Pulmonary and Respiratory Medicine Image-Guided Biopsy Male medicine.medical_specialty bronchoscopy medicine.medical_treatment cryobiopsy Lesion 03 medical and health sciences 0302 clinical medicine Bronchoscopy Interquartile range Biopsy medicine Humans Sampling (medicine) Prospective Studies navigation RC254-282 Aged Lung medicine.diagnostic_test business.industry peripheral pulmonary nodule Neoplasms. Tumors. Oncology. Including cancer and carcinogens Solitary Pulmonary Nodule General Medicine Original Articles Middle Aged medicine.disease Chest tube 030104 developmental biology medicine.anatomical_structure Oncology Pneumothorax 030220 oncology & carcinogenesis Fluoroscopy diagnostic yield Multiple Pulmonary Nodules Female Original Article Radiology medicine.symptom business |
Zdroj: | Thoracic Cancer Thoracic Cancer, Vol 12, Iss 13, Pp 2007-2012 (2021) |
ISSN: | 1759-7714 |
Popis: | Background The LungVision system is a novel augmented‐fluoroscopy‐based real‐time navigation and guidance technology for bronchoscopy that can be integrated with any standard biopsy tool, including the cryoprobe, to enable real‐time visualization and localization of pulmonary nodules. Objectives To evaluate the diagnostic yield and safety among patients undergoing peripheral pulmonary nodule biopsy with the LungVision system. Methods This prospective, single‐center study was conducted at Rabin Medical Center in Israel. All patients that underwent peripheral pulmonary nodule biopsy with the LungVision system from January 2016 to August 2020 were included. All procedures were performed under moderate sedation. The primary outcome was tissue diagnosis by either identification of malignant cells or benign diagnosis. Secondary outcomes were safety and the added value of cryobiopsy. Results Sixty‐three procedures were performed during the study period. Median lesion size (interquartile range) was 25.0 mm (18–28 mm). The diagnostic yield overall was 27/33 (81.8%) and for lesions smaller than 20 mm was 13/18 (72.2%). In nine cases the transbronchial cryobiopsy showed tissue with malignant cells that were not found in any other biopsy material taken with other sampling tools. One patient was treated with a chest tube for a pneumothorax. No other major complications were reported. Conclusions The LungVision system showed good feasibility and safety for peripheral pulmonary nodule biopsy. The system is compatible with all biopsy tools, including the cryoprobe. Randomized controlled trials are needed to accurately ascertain its diagnostic yield. The LungVision fluoroscopy‐based navigation and guidance technology for bronchoscopic biopsy of peripheral pulmonary nodules is safe and effective. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |